Two doses of the vaccine provided complete protection against both inhalational anthrax and pneumonic plague in animal models. Further, results establish the T4 nanoparticle as a novel platform to develop multivalent vaccines against pathogens of high public health significance.
The Walter Reed Army Institute of Research (WRAIR) this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Accepting that antibiotics are infrastructure would change our relationship to the drugs, forcing us to recognize that medicine requires long-term planning.
Technique may also apply to salmonella and production of a single bacteria for immunizing poultry against several salmonella serogroups.
A novel synthetic DNA vaccine offers complete protection from Zaire Ebolavirus infection in promising preclinical research.
A new vaccine against both rabies and Lassa has demonstrated effective protection in animal models of disease, the research also points to a new way to test for protection against the Lassa fever virus, a finding that could significantly speed vaccine development.
Recent research outlines how near-infrared spectroscopy could be used to make cell-culture-based flu vaccine manufacturing faster and more efficient.
University of Texas Medical Branch (UTMB) researchers have developed a less expensive way to produce vaccines that cuts the cost of vaccine production and storage by 80 percent without decreasing safety or effectiveness.
The new E coli-fighting tactic uses CRISPR DNA to systematically perturb gene expression in the bacteria.
G20 leaders will come together to simulate a fictional drug-resistant E. Coli pandemic, as part of an international effort to tackle antimicrobial resistance (AMR).